According to Can Fite Biopharma 's latest financial reports the company's current earnings (TTM) are -$9.01 M. In 2022 the company made an earning of -$10.18 M an increase over its 2021 earnings that were of -$12.62 M.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | -$9.01 M | -11.52% |
2022 | -$10.18 M | -19.36% |
2021 | -$12.62 M | -12.66% |
2020 | -$14.45 M | 50.65% |
2019 | -$9.59 M | 45.99% |
2018 | -$6.57 M | 20.87% |
2017 | -$5.44 M | -22.3% |
2016 | -$7 M | 38.19% |
2015 | -$5.07 M | -19.58% |
2014 | -$6.3 M | -28.12% |
2013 | -$8.76 M | -35.99% |
2012 | -$13.68 M | 133.95% |
2011 | -$5.85 M |